ANDREA MAGGARD: Open Payments
NPI 1790818250 · HAMPSTEAD, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$899 in 48 payments from 16 companies in 2025. Trend: 2023 $579 · 2024 $816 · 2025 $899
Food & beverage: $899
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $190 |
| Almatica Pharma LLC | 5 | $90 |
| Novo Nordisk Inc | 5 | $80 |
| Janssen Pharmaceuticals, Inc | 3 | $75 |
| Lilly USA, LLC | 3 | $73 |
| AstraZeneca Pharmaceuticals LP | 4 | $73 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $71 |
| Exact Sciences Corporation | 2 | $44 |
| PFIZER INC. | 2 | $42 |
| Corcept Therapeutics | 2 | $37 |
Products named: VRAYLAR, LOREEV XR, SPRAVATO, CAPLYTA, AIRSUPRA, MOUNJARO, QULIPTA, Korlym.
Industry payments across NC — which companies pay providers there.
